Data are processed for the conduct of the carbapenem- and/or colistin-resistant Enterobacteriaceae (CCRE) survey as part of molecular surveillance of antimicrobial resistant pathogens according to a protocol. For the CCRE survey bacterial isolates (carbapenem and/or colistin-resistant Enterobacteriaceae and susceptible control isolates) and related patient data are collected in hospitals in 37 countries with the aim to determine transmission pathways and improve control measures.
This document sets out the strategic priorities for all six ECDC disease-specific programmes from 2010 to 2013 based on a short description of the epidemiological background, the context in which ECDC works on that specific disease or disease group, and defined gaps that require action at the EU level.